Julia Bianca Herring, FNP-BC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 3528 Holborn Dr, Hope Mills, NC 28348 Phone: 910-670-6031 |
Barbara Dust Keith, F.N.P. Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1249 Chicken Foot Rd, Hope Mills, NC 28348 Phone: 910-423-1278 Fax: 910-423-2547 |
Jennifer Baggett, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7021 Pope Cashwell Court, Hope Mills, NC 28348 Phone: 910-627-1581 |
Honglian Jin, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 3436 N Main St, Hope Mills, NC 28348 Phone: 910-426-7337 |
Dr. Shelia Maria Black, DNP, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3758 S Main St, Hope Mills, NC 28348 Phone: 910-429-0647 Fax: 910-429-0791 |
Mrs. Jennifer Smith, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 4092 Professional Dr, Hope Mills, NC 28348 Phone: 910-615-3120 Fax: 910-423-6050 |
Ms. Tammy Mcduffie, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 741 Pecan Grove Loop, Hope Mills, NC 28348 Phone: 910-797-0500 |
Esther Okons, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 3758 S Main St, Hope Mills, NC 28348 Phone: 910-429-0647 Fax: 910-429-0791 |
Gaitrice Martin, MSN, APRN, FNP-BC Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 540 Grand Wailea Dr Apt 817, Hope Mills, NC 28348 Phone: 205-354-5559 |
News Archive
WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).
A new test developed by Japanese scientists may revolutionize how and when physicians diagnose Alzheimer's disease.
In a study published online February 25, 2021 in The New England Journal of Medicine, a repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia.
Scientists report in the November 2007 issue of the Journal of Lipid Research that the concentration of a compound called apolipoprotein B in the blood is better at predicting whether Chinese have coronary heart disease – in which fatty deposits clog arteries that supply blood and oxygen to the heart – than other substances such as blood cholesterol levels.
› Verified 6 days ago